In this file
Hers membership and medication are separate charges with different cancellation effects. That detail matters when comparing the proposed prescription, payment schedule, and access to help.
This provider file follows the company’s published material and the questions it leaves open. It covers the care arrangement, price, cancellation boundaries, and contact routes; it does not certify the business or determine whether a treatment is appropriate for a particular person.
Understand the care arrangement
Hers describes a weight-loss membership that provides clinical support and access to medication evaluation. Membership benefits are separate from the prescription itself. Joining the service does not guarantee a prescription, and the reviewed FAQ states that GLP-1 access is not available in every state.
Name the organizations involved in your own plan. The website operator, clinical practice, and pharmacy may be separate businesses. A patient should know which one is responsible for a medical decision, which holds the account, and which handles the medication.
Read the price in its proper context
The membership page lists $39 for the first month followed by $149 per month, excluding medication. Medicine is billed separately under the selected plan. Build the budget from both charges and confirm the medication’s own renewal price rather than using the membership promotion as the total cost.
Record the total paid today, the period it buys, and the next payment. If a figure is expressed per month but collected for several months, keep both numbers in the comparison. Our price-comparison worksheet helps separate a low initial figure from the continuing commitment.
Find the cancellation boundary
Hers explains that cancelling membership also ends active medication plans and platform care, while cancelling medication alone leaves membership active. A patient who wants all future payments stopped should identify both components. The remaining financial obligation under a prepaid medication plan still needs to be checked.
A useful request names the next renewal and the current order separately. Ask for confirmation of both the effective cancellation date and the pharmacy status. Instructions for stopping or changing the medicine itself need to come from the treating professional.
Identify the actual prescription
The current FAQ describes access to approved GLP-1 products and requires clinician assessment for new or transferring patients. A transfer request is not an automatic continuation of a previous prescription. Ask the receiving clinician how the medication history and follow-up needs will be reviewed.
FDA approval concerns a particular drug product. A compounded preparation has not received that approval, and evidence for a different formulation cannot guarantee an individual result. Read the product-approval explanation and ask questions about the exact medicine proposed.
Contact and account help
A general patient telephone number or email was not established from the documents selected for this file. We leave that gap visible rather than reconstructing a masked address or publishing an unrelated department’s number.
A general patient phone and email were not established from the selected documents. Start with the official website and its patient-support navigation.
Start from the official Hers website to find its verified patient-account navigation. We have not signed into a private portal or measured its support response. Do not share passwords, access codes, payment-card details, or medical records with a review site.
Bring one concrete question to the consultation
If I end my medication plan, will membership continue, and what total recurring amount will I pay after the first month?
Write the answer beside the proposed prescription and agreement. If it describes a different product, an expired promotion, or a plan you are not eligible for, ask for clarification. Our pre-purchase checklist can help keep those questions organized.
Compare a different arrangement
The Hers alternatives guide compares care and payment structures relevant to this file. CoreAge Rx’s first place in that list is a disclosed commercial placement, not an independent clinical ranking.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- Hers weight-loss FAQ ↗Provider-published information · Checked September 22, 2026
- Hers weight-loss membership ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026